MKI67 and breast cancer: Using 18F-FDG PET/CT-based images of locally advanced breast cancer before and after neoadjuvant therapy, the tumor heterogeneity texture parameters were extracted, and the obtained metabolomic patterns correlated with ki67 expression, pCR rate, and risk of recurrence after neoadjuvant [92].